Proposed Alzheimer's disease and dementia topics
- Can the diagnosis of AD be made solely on biomarker evidence?
- Does cognitive stimulation have value in the treatment of MCI and early AD?
- Does general anesthesia increase the risk of dementia?
- Is amyloid deposition a non-specific manifestation of aging?
- Should agitation in AD be treated with antipsychotics?
- Is obstructive sleep apnea an important risk factor for dementia?
- The clinical criteria of NPH are sensitive and predictive of response to shunting.
- Is inflammation a valid target for intervention in AD?
- Is TBI a risk for dementia?
- The term Alzheimer's disease should be dropped as it is impeding future research.
Dementia plenary lectures
- Neuroinflammation in neurodegeneration - friend or foe?
- Transmission of human AD
- How robotic technology can help in long term care of dementia patients?
- Pharmacological treatment of AD in the year 2028
- Are tau strains significant in human disease?
- Why have we failed to cure AD?
List of invited speakers
|
Maria Barcikowska, Poland
Roger Bullock, UK Ornit Chiba-Falek, USA Marek Czosnyka, UK Daniel Drubach, USA Lawrence Friedhoff, USA Tomasz Gabryelewicz, Poland Michael Geschwind, USA Ezio Giacobini, Switzerland Panteleimon Giannakopoulos, Switzerland Lawrence Honig, USA Miia Kivipelto, Finland David Knopman, USA Amos Korczyn, Israel Giancarlo Logroscino, Italy |
Virginia M. Y. Lee, USA
Lefkos Middleton, UK Agneta Nordberg, Sweden Dan Perl, USA Robert Perneczky, UK Marios Polotis, UK Konrad Rejdak, Poland Dorota Religa, Sweden Isabel Santana, Spain Filip Scheperjans, Finland Reinhold Schmidt, Austria Luiza Spiru, Romania Babak Tousi, USA John Trojanowski, USA Magda Tsolaki, Greece |
